Inhibrx Biosciences, Inc. announced a private placement that it has issued 1,838 shares of common stock and warrants to purchase 7,354 shares of common stock at a per share exercise price of $17 per share on May 29, 2024. The transaction will include participation from new investor, Oxford Finance LLC.